Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;31(3):527-546.
doi: 10.1016/j.soc.2022.03.011.

Leiomyosarcoma: Current Clinical Management and Future Horizons

Nicolas Devaud  1 , Olga Vornicova  2 , Albiruni R Abdul Razak  2 , Korosh Khalili  3 , Elizabeth G Demicco  4 , Cristina Mitric  5 , Marcus Q Bernardini  5 , Rebecca A Gladdy  6
Affiliations
Review

Leiomyosarcoma: Current Clinical Management and Future Horizons

Nicolas Devaud et al. Surg Oncol Clin N Am. 2022 Jul.

Abstract

Leiomyosarcomas are soft tissue tumors that are derived from smooth muscle mainly in the pelvis and retroperitoneum. Percutaneous biopsy is paramount to confirm diagnosis. Imaging is necessary to complete clinical staging. Multimodal treatment should be directed by expert sarcoma multidisciplinary teams that see a critical volume of these rare tumors. Surgery is the mainstay of curative intent treatment; however due to its high metastatic progression, there may be a benefit for neoadjuvant systemic treatment. Adjuvant systemic treatment has no proven disease-free survival, and its main role is in the palliative setting to potentially prolong overall survival.

Keywords: Leiomyosarcoma; Metastasis; Retroperitoneum; Soft tissue sarcoma; Systemic treatment; Uterine sarcoma; Vascular origin.

PubMed Disclaimer